CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

    NEXT STORY
    Kinross reports 2019 fourth-quarter and full-year results
    PREV STORY
    Ascendis Pharma A/S Announces Upcoming Investor Presentation in February
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

    author_avatar
    NASDAQ Market News

    Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer

    GAITHERSBURG, Md., March 14, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the ...

    author_avatar
    NASDAQ Market News

    Innovation Pharmaceuticals Completes End-of-Phase 2 Meeting with FDA; Brilacidin Oral Rinse to Advance Into Phase 3 Clinical Trials for Prevention of Severe Oral Mucositis

    BEVERLY, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

    author_avatar
    NASDAQ Market News